Celldex Therapeutics, Inc. (CLDX)
NASDAQ: CLDX · Real-Time Price · USD
23.39
+1.33 (6.03%)
Sep 3, 2025, 11:44 AM - Market open
Celldex Therapeutics Analyst Ratings
Total Analysts
9
Consensus Rating
Strong Buy
Price Target
$46.13
Upside
+97.22%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $44 → $38 | Buy | Maintains | $44 → $38 | +62.46% | Aug 20, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $56 → $48 | Strong Buy | Maintains | $56 → $48 | +105.22% | Aug 20, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $64 → $62 | Strong Buy | Maintains | $64 → $62 | +165.07% | Aug 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $50 → $42 | Strong Buy | Maintains | $50 → $42 | +79.56% | Aug 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +113.77% | Jun 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +113.77% | Jun 13, 2025 |
| UBS | UBS | Strong Buy Maintains $44 → $38 | Strong Buy | Maintains | $44 → $38 | +62.46% | May 9, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $36 → $31 | Hold | Maintains | $36 → $31 | +32.54% | May 9, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $46 → $43 | Buy | Maintains | $46 → $43 | +83.84% | May 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $80 → $50 | Strong Buy | Maintains | $80 → $50 | +113.77% | May 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +242.03% | May 6, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $64 | Strong Buy | Initiates | $64 | +173.62% | Apr 28, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $46 | Buy | Initiates | $46 | +96.67% | Mar 20, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $42 → $36 | Hold | Maintains | $42 → $36 | +53.91% | Mar 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +242.03% | Mar 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +242.03% | Feb 28, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.